Minerva Neurosciences (NERV) Interest Expenses (2013 - 2026)

Minerva Neurosciences' Interest Expenses history runs 14 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• Quarterly Interest Expenses changed N/A year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (changed N/A YoY) and the FY2025 annual result came in at $99.7 million, up 3.76% from the prior year.
• Interest Expenses was $16.3 million for Q1 2026 at Minerva Neurosciences, up from $1.3 million in the prior quarter.
• Across five years, Interest Expenses topped out at $96.9 million in Q4 2023 and bottomed at $17000.0 in Q2 2024.
• A 5-year average of $20.8 million and a median of $1.2 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2024 — Interest Expenses sank 99.95% — and 2025, when it jumped 2660.87%.
• Minerva Neurosciences' Interest Expenses stood at $90.1 million in 2022, then gained by 7.5% to $96.9 million in 2023, then sank by 99.95% to $46000.0 in 2024, then soared by 2660.87% to $1.3 million in 2025, then soared by 1181.1% to $16.3 million in 2026.
• Business Quant data shows NERV's Interest Expenses at $16.3 million in Q1 2026, $1.3 million in Q4 2025, and $46000.0 in Q4 2024.